(Q57749178)

English

Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2

scientific article published on 01 May 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

0 references

1 reference

based on heuristic

inferred from title

Licia Rivoltini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Carlo Gambacorti-Passerini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

F Arienti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

F Belli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

L Furlan

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

L Mascheroni

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

A Prada

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

M Rizzi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

E Marchesi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

M Vaglini

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1 May 1993

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

315-322

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

https://scigraph.springernature.com/pub.10.1007/bf01741170

0 references

Class I major histocompatibility complex enhancement by recombinant leukocyte interferon in the peripheral blood mononuclear cells and plasma of melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective changes in expression of HLA class I polymorphic determinants in human solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of murine tumor class I major histocompatibility complex expression on antitumor activity of tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokines and cancer: experimental systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can oncogene (RAS) activation predict susceptibility of human melanoma to activated lymphocytes and, therefore, the clinical response of such neoplasms to adoptive immunotherapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An improved method for growing murine tumor-infiltrating lymphocytes with in vivo antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of HLA phenotype with response to active specific immunotherapy of melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immunoaugmenting effects of cancer chemotherapeutic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/8477417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01741170

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8477417%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57749178&oldid=1753825528"